The UCLA Clinical and Translational Science Institute (CTSI) is a collaboration of UCLA, Cedars-Sinai, Charles R. Drew University, and Lundquist-Harbor-UCLA. The TL1 prepares predoctoral trainees to conduct translational research that will improve care delivery for populations. The CTSI envisions the TL1 program as a training opportunity for a next generation of scholars with the expertise and training to make the LHS a reality.
TL1 trainees will learn to employ methods that leverage modern data systems and learn to develop the skills and approaches needed to continuously improve healthcare and public systems. Trainees will also acquire the fundamental competencies of translation as preparation to apply them to real-world problems in systems. The TL1 emphasizes the health of populations, and health equity.
Areas of focus include biomedical informatics and data science, the science of implementation and dissemination, and system science. All TL1 trainees are taught and mentored by a multidisciplinary faculty with experience in translational science and research mentorship and by research champions from the entities and medical centers that collaborate in the UCLA CTSI.
The TL1 leverages UCLA, CDU, Cedars-Sinai, and Harbor-Lundquist faculty to provide curriculum and mentorship that enable each trainee to acquire translational competencies and become well versed in the application of relevant methods. The program:
Applying to the TL1
Applications for the 2023 CTSI TL1 predoctoral program are open until January 20, 2023. Eligibility and application require the following:
Funding is renewed on an annual basis based on academic excellence and progress within the program. Predoctoral trainees are eligible for up to three years of TL1 funding.
To apply: https://bit.ly/TL1PREDOC
If preferred, faculty can submit their letters of recommendation separately at: https://bit.ly/TL1-LOR
Questions about the program are encouraged. Email: CTSIWD@mednet.ucla.edu